Rochester, Minnesota 55905


Purpose:

Hypothesis: Increased contact with the diabetes care team throughout pregnancy will lead to improved glucose control during pregnancy.


Study summary:

Patient will have weekly contact through the Mayo Patient On-line Services to send in their blood glucose readings and to receive recommendations back regarding insulin dose changes. Information will be analyzed regarding the magnitude of change in insulin dosing and in glycemic variability.


Criteria:

Inclusion Criteria: - Adult pregnant women with type 1 diabetes utilizing either an insulin pump or multiple daily injection insulin program to manage their diabetes Inclusion Criteria: - Female with type 1 diabetes and pregnancy - EDD prior to November 15, 2014 - 18 years of age and older - On insulin pump or multiple daily injection insulin program - Signed patient consent form Exclusion Criteria: - Exclusion Criteria: - Female with type 1 diabetes and pregnancy under age 18 or older than age 45 - Female with type 2 diabetes or gestational diabetes and pregnancy


NCT ID:

NCT02315274


Primary Contact:

Donna M. Desjardins, CNP
Phone: 5072556869
Email: desjardins.donna@mayo.edu


Backup Contact:

Email: kudva.yogish@mayo.edu
Yogish C Kudva, MD
Phone: 507 284 3964


Location Contact:

Rochester, Minnesota 55905
United States

Donna M Desjardins, CNP
Phone: 507-255-6869
Email: desjardins.donna@mayo.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.